Nanoscope in the News
-
OPN: Nanoscope Therapeutics Publishes Clinical Data Demonstrating Vision Restoration in Retinitis Pigmentosa
March 28, 2025 by Wilson PJ
-
Ophthalmology 360: VIDEO: Two-year results of RESTORE study highlight a mutation-agnostic gene therapy for retinitis pigmentosa
October 31, 2024 by Nanoscope Therapeutics
-
Healio/Ocular Surgery News: VIDEO: Nanoscope Therapeutics shares status update
October 28, 2024 by Nanoscope Therapeutics
-
HCP Live: VIDEO: Allen C. Ho, MD: Efficacy, Safety of MCO-010 for Retinitis Pigmentosa at 2 Years
October 24, 2024 by Nanoscope Therapeutics
-
Healio/Ocular Surgery News: VIDEO: Optogenetic therapy trial in retinitis pigmentosa meets safety, efficacy endpoints
October 21, 2024 by Nanoscope Therapeutics
-
Ophthalmology Times: AAO 2024: New gene therapy shows promise for treatment of retinitis pigmentosa
October 20, 2024 by Nanoscope Therapeutics
-
Ocular Surgery News: VIDEO: Optogenetic therapy shows promise for inherited retinal dystrophies
October 1, 2024 by Nanoscope Therapeutics
-
Max-Planck-Gesellschft: Nanoscope Therapeutics licenses optogenetic technology
September 30, 2024 by Nanoscope Therapeutics
-
HCP Live: Nanoscope Reports Positive End-of-Phase 2 Meeting for MCO-010 Gene Therapy
September 13, 2024 by Nanoscope Therapeutics
-
Retina Specialist: ARVO 2024 Highlights – Optogenetic therapy for retinitis pigmentosa yields BCVA improvement at one year
August 21, 2024 by Nanoscope Therapeutics
-
Ocular Surgery News: VIDEO: MCO-010 for retinitis pigmentosa improves vision in phase 2b/3 study
August 11, 2024 by Nanoscope Therapeutics
-
Modern Retina: ASRS 2024: RESTORE trial 100-week results presented by Dr. Michael Singer
July 27, 2024 by Nanoscope Therapeutics
-
Ocular Surgery News: VIDEO: Optogenetic therapy shows vision improvements, safety at 12 months
May 7, 2024 by Nanoscope Therapeutics
-
Longevity Technology: Nanoscope targets FDA approval following positive gene therapy trial results
March 28, 2024 by Nanoscope Therapeutics
-
Pharmaceutical Technology: Nanoscope Therapeutics exhibits positive top-line Phase IIb results for MCO-010
March 28, 2024 by Nanoscope Therapeutics
-
Ocular Surgery News: Gene therapy improves vision in patients with retinitis pigmentosa in phaase 2b trial
March 27, 2024 by Nanoscope Therapeutics
-
Modern Retina: Nanoscope Therapeutics lead candidate MCO-010 meets endpoints in RESTORE trial for retinitis pigmentosa
March 26, 2024 by Nanoscope Therapeutics
-
Pharmaphorum: Nanoscope preps filing for retinitis pigmentosa gene therapy
March 26, 2024 by Nanoscope Therapeutics
-
Fierce Biotech: Nanoscope eyes market after gene therapy restores vision for patients with retinal disease
March 26, 2024 by Nanoscope Therapeutics
-
Modern Retina : https://www.modernretina.com/view/mco-010-optogenetic-gene-therapy-for-severe-vision-loss-in-stargardt-disease
November 20, 2023 by Nanoscope Therapeutics